Participants were alcohol-dependent individuals ( N = 1,156 ; 357 women ) recruited at 11 outpatient academic alcoholism-treatment clinics across the United States to participate in a randomized , double-blind , placebo-controlled trial that combined behavioral intervention with acamprosate and/or naltrexone .